Marampon F, Gravina G L, Festuccia C, Popov V M, Colapietro A, Sanità P, Musio D, De Felice F, Lenzi A, Jannini E A, Di Cesare E, Tombolini V
Division of Radiotherapy and Radiobiology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
J Endocrinol Invest. 2016 Apr;39(4):411-22. doi: 10.1007/s40618-015-0381-9. Epub 2015 Sep 3.
Radiotherapy toxicity is related to oxidative stress-mediated endothelial dysfunction. Here, we investigated on radioprotective properties of Vitamin D (Vit.D) on human endothelial cells (HUVEC).
HUVEC, pre-treated with Vit.D, were exposed to ionizing radiation (IR): ROS production, cellular viability, apoptosis, senescence and western blot for protein detection were performed. The role of MAPKs pathway was investigated by using U0126 (10 μM) MEKs/ERKs-, SB203580 (2.5 μM) p38-inhibitor or by over/expressing MKK6 p38-upstream activator.
Vit.D reduced IR-induced ROS production protecting proliferating and quiescent HUVEC from cellular apoptosis or senescence, respectively, by regulating MAPKs pathways. In proliferating HUVEC, Vit.D prevented IR-induced apoptosis by activating ERKs while in quiescent HUVEC counteracted IR-induced senescence by inhibiting the p38-IR-induced activation. MEKs&ERKs inhibition in proliferating or MKK6/mediated p38 activation in quiescent HUVEC, respectively, reverted anti-apoptotic or anti-senescent Vit.D properties. SirT1 protein expression levels were up-regulated by Vit.D. ERKs inhibition blocked Vit.D-induced SirT1 protein up-regulation in proliferating cells. In quiescent HUVEC cells, p38 inhibition counteracted the IR-induced SirT1 protein down-regulation, while MKK6 transfection abrogated the Vit.D positive effects on SirT1 protein levels after irradiation. SirT1 inhibition by sirtinol blocked the Vit.D radioprotective effects.
Vit.D protects HUVEC from IR induced/oxidative stress by positively regulating the MAPKs/SirT1 axis.
放射治疗毒性与氧化应激介导的内皮功能障碍有关。在此,我们研究了维生素D(Vit.D)对人内皮细胞(HUVEC)的辐射防护特性。
用Vit.D预处理HUVEC,然后使其暴露于电离辐射(IR):检测活性氧(ROS)生成、细胞活力、凋亡、衰老情况,并进行蛋白质检测的蛋白质印迹分析。通过使用U0126(10μM)抑制MEKs/ERKs、SB203580(2.5μM)抑制p38或通过过表达/表达MKK6(p38上游激活剂)来研究丝裂原活化蛋白激酶(MAPKs)途径的作用。
Vit.D通过调节MAPKs途径减少IR诱导的ROS生成,分别保护增殖期和静止期的HUVEC免于细胞凋亡或衰老。在增殖期HUVEC中,Vit.D通过激活ERK来防止IR诱导的凋亡,而在静止期HUVEC中,通过抑制p38-IR诱导的激活来抵消IR诱导的衰老。分别抑制增殖期HUVEC中的MEKs&ERKs或静止期HUVEC中MKK6介导的p38激活,可逆转Vit.D的抗凋亡或抗衰老特性。Vit.D上调沉默调节蛋白1(SirT1)蛋白表达水平。抑制ERK可阻断Vit.D诱导的增殖期细胞中SirT1蛋白上调。在静止期HUVEC细胞中,抑制p38可抵消IR诱导的SirT1蛋白下调,而转染MKK6可消除照射后Vit.D对SirT1蛋白水平的积极影响。用sirtinol抑制SirT1可阻断Vit.D的辐射防护作用。
Vit.D通过正向调节MAPKs/SirT1轴保护HUVEC免受IR诱导的氧化应激。